Abeona Therapeutics (ABEO) SEC Filings: History & Chart

Abeona Therapeutics Inc.(ABEO)

Biotechnology · Cleveland, OH

$5.02-0.10 (-1.86%)

Delayed quote: Oct 6, 2026, 2:40 PM EDT

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended for CLN3 disease. ABO-401, developed to treat cystic fibrosis. ABO-50X, aimed at various genetic eye disorders. Additionally, Abeona is advancing AAV-based gene therapy solutions through its proprietary AIM vector platform. The company, which was founded in 1974 and is headquartered in New York, New York, changed its name to Abeona Therapeutics Inc. in June 2015, having previously been known as PlasmaTech Biopharmaceuticals, Inc.

Cleveland, OH

226 employees

www.abeonatherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Vishwas Seshadri

View full financials

Form	Filing Date	Accepted	Document
4	Sep 29, 2026	Sep 29, 2026	View filing
4	Sep 29, 2026	Sep 29, 2026	View filing
4	Sep 29, 2026	Sep 29, 2026	View filing
4	Sep 29, 2026	Sep 29, 2026	View filing
8-K	Sep 15, 2026	Sep 15, 2026	View filing
4	Sep 1, 2026	Sep 1, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
10-Q	Aug 13, 2026	Aug 13, 2026	View filing
8-K	Aug 13, 2026	Aug 13, 2026	View filing
4	Jul 22, 2026	Jul 22, 2026	View filing
424B3	Jul 10, 2026	Jul 10, 2026	View filing
4	Jul 9, 2026	Jul 9, 2026	View filing
4	Jul 9, 2026	Jul 9, 2026	View filing
4	Jul 9, 2026	Jul 9, 2026	View filing
4	Jul 9, 2026	Jul 9, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
S-8	Jun 26, 2026	Jun 26, 2026	View filing
4	Jun 17, 2026	Jun 17, 2026	View filing
4	Jun 15, 2026	Jun 15, 2026	View filing
8-K	Jun 12, 2026	Jun 12, 2026	View filing
8-K	Jun 12, 2026	Jun 12, 2026	View filing
8-K	Jun 10, 2026	Jun 10, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
8-K	Jun 4, 2026	Jun 4, 2026	View filing
4	May 26, 2026	May 26, 2026	View filing
4	May 22, 2026	May 22, 2026	View filing
4	May 15, 2026	May 15, 2026	View filing

SEC Filings

Recent Filings